Lightening Talks and Networking Opportunities Cytokines 2024 and KAI 2024 is your unique opportunity to learn from global thought leaders in Cytokine and Interferon research and gain the insights, techniques, and experiences you need to build a vital network to amplify your impact. Event highlights include opportunities to: Meet senior [READ MORE]
Pegylated Interferon Lambda for Treatment of COVID-19 Infection | Proportion of Clinical Improvement & Type 1 Interferon (IFN) Score Changes in Idiopathic Uveitis Patients With Interferon Gamma Release Assay (IGRA) Positive | Allogeneic Hematopoietic Cell Transplantation With Pegylated Interferon Alfa-2a for Primary and Secondary Myelofibrosis (ATIOM) [READ MORE]
Dr. Claudia Nold Ph.D., 2024 Nominations Committee Chairperson, is pleased to announce the results of the 2024 ICIS Leadership elections! Susan Carpenter, Ph.D., University of California at Santa Cruz and Judith Allen, Ph.D., University of Manchester were re-elected as Secretary and Council Member, respectively. We welcome Joanna Groom, Ph.D. Walter [READ MORE]
Announcing the 3rd Annual Memorial Lecture to be given by Curt Horvath at Cytokines 2024 / KAI 2024 Joint Meeting in Seoul. The 2024 Jürg Tschopp Memorial Symposium will be held on October 20 (Sun) 15:10-16:50, Symposium 1: IFNs and Inflammation. Professor Horvath will speak on Positive and negative regulation of interferon signaling and antiviral immunity. [READ MORE]
Philip I. Marcus Memorial Speaker: Barbara Rehermann, MD, (NIH, USA), to speak on Wild-derived microbiota regulate host immune responses and disease outcome in preclinical models2024 Philip I. Marcus Memorial Symposium 4:Host-microbiota Interaction, in the 2024 Philip I. Marcus Memorial Symposium 4: Host-microbiota Interaction, sponsored by Mary Ann Liebert, Inc. Publishers and the JICR Journal. [READ MORE]
Cytokines 2024 and KAI 2024 is your unique opportunity to learn from global thought leaders in Cytokine and Interferon research and gain the insights, techniques, and experiences you need to build a vital network to amplify your impact. This exciting week of science and conversation concludes with a one-of-a-kind event: [READ MORE]
My research focuses on immune metabolism and cancer microenvironment, and as a surgeon-scientist in training, I am deeply interested in improving the outcomes of liver cancer patients. Regarding my hobbies, I really like swimming. Lastly, the best advice I’ve received is that life is an experience. This simple yet profound [READ MORE]
Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma (ATPIC) | Effectiveness of Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon for Treatment of HIV | Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia [READ MORE]
Regulatory T cells (Tregs) are essential for resolving inflammation and maintaining immune homeostasis. How Tregs are locally regulated in inflamed niches is poorly understood, although their expression of CD4 helper T (Th) cell lineage-defining transcription factors (i.e. Gata3, Rorγt, and Tbet) tailors their regulatory function towards a specific type of [READ MORE]
My research focuses on understanding the cytokine and metabolic regulation of regulatory T cells residing in non-lymphoid tissues such as the visceral adipose tissue and skin. I started my lab at Emory University in 2020, right at the beginning of the COVID pandemic. It was difficult but I received a [READ MORE]
International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy
